DEC 27, 2018 04:13 PM PST

Unapproved Stem Cell Treatments Sickened Over a Dozen People Last Year

WRITTEN BY: Carmen Leitch

The Centers for Disease Control and Prevention (CDC) found that at least a dozen people were sickened last year by unapproved stem cell treatments. Three of those patients were subjected to procedures with reagents made by Genetech, Inc. That company and others have been warned by the Food and Drug Administration (FDA) to correct the violations they have been notified about, and that failure to do so may result in “seizure or injunction.”

“The FDA is committed to advancing the field of cell-based regenerative medicine. We’re implementing new policies to make it more efficient to safely develop these promising new technologies. At the same time, we’re also focusing more resources on enforcement when we see companies skirt safety measures and put patients at risk. In this case, the company’s failure to put in place appropriate safeguards may have led to serious blood infections in patients,” said FDA Commissioner Scott Gottlieb, M.D. in a statement.

“We remain committed to supporting the development of safe and effective cell-based regenerative medicine and advancing our comprehensive regenerative medicine policy framework. These efforts include our work to encourage manufacturers to engage with the FDA early so that we can provide guidance about any applicable regulatory requirements. Even though a few sponsors have come to us, we are discouraged by the overall lack of manufacturers wanting to interact with the agency in this enforcement discretion period. The letters we’re issuing today to manufacturers, health care providers and clinics around the country are a reminder that there’s a clear line between appropriate development of these products and practices that sidestep important regulatory controls needed to protect patients. Time is running out for firms to come into compliance during our period of enforcement discretion. We’ll be increasing our oversight related to cell-based regenerative medicine as part of our comprehensive plan to promote beneficial innovation while protecting patients.”

Sources: CDC, FDA

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
FEB 12, 2019
Cardiology
FEB 12, 2019
Meditation May Be Helpful Addition To Care For Heart Disease Patients
Research has shown that stress is not good for the heart. To combat stress, some people participate in meditation practices. A number of studies, across bo...
FEB 17, 2019
Cardiology
FEB 17, 2019
Meditation Helps Smokers Quit
Cigarettes are a leading contributor to preventable disease and deaths in the United States. Smoking accounts for one in five American deaths. Of those who...
FEB 17, 2019
Videos
FEB 17, 2019
How did you celebrate World Pangolin Day?
World Pangolin Day is celebrated the third Saturday of February every year in order to bring awareness to the world of this lovely little scaly anteater - ...
FEB 21, 2019
Videos
FEB 21, 2019
A Review of Organoids
To study biology and human disease, researchers can choose from a variety of models to use in their work. Organoids are a new option....
MAR 07, 2019
Videos
MAR 07, 2019
Sleep Loss Intensifies Pain
It may seem obvious to some, but researchers have found evidence that when people lose sleep, they become more sensitive to pain....
MAR 17, 2019
Health & Medicine
MAR 17, 2019
Innovative Tests For Early Parkinson's Diagnosis
As medicine turns away from treatment and towards prevention, diagnostic tools have become a focus of researchers. The earlier disease can be detected the...
Loading Comments...